BioLineRx Ltd. BLRX
1.91 USD -0.04 (-2.05%)
At closeNov 3, 2026, 4:00 PM EST
1.91 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.90 Day range 1.99
1.90 52-week range 3.95
- YTD
- -31.05%
- 1 year
- -44.96%
Analyst view
Price target (mean) 4.57 +139.1% upside
Now 1.91
- Target (low)
- 2.00
- Target (mean)
- 4.57
- Target (high)
- 9.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.0894 | +100.0% | 7.72M | +60.8% | 1 |
| Next quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 792.00K | -88.4% | 1 |
| Current year | -0.08 | -0.08 – -0.08 | -0.8394 | +90.5% | 24.91M | +419.0% | 1 |
| Next year | -0.11 | -0.11 – -0.11 | -0.08 | -37.5% | 4.29M | -82.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 25, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Feb 23, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 16, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 4, 2017 | Oppenheimer | Initiated | — | Outperform |
| May 18, 2017 | Maxim Group | Upgrade | Hold | Buy |
| Feb 13, 2017 | Rodman & Renshaw | Initiated | — | Buy |
| Aug 12, 2016 | Maxim Group | Downgrade | Buy | Hold |
| Mar 9, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Jun 22, 2015 | JMP Securities | Initiated | — | Outperform |
| Jun 22, 2015 | JP Morgan | Initiated | — | Market Outperform |